Compagnie Lombard Odier SCmA’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-87
Closed 872
2016
Q4
$0 Hold
87
﹤0.01% 882
2016
Q3
$0 Hold
87
﹤0.01% 944
2016
Q2
$0 Hold
87
﹤0.01% 999
2016
Q1
$0 Hold
87
﹤0.01% 1035
2015
Q4
$1K Hold
87
﹤0.01% 934
2015
Q3
$1K Hold
87
﹤0.01% 802
2015
Q2
$1K Hold
87
﹤0.01% 817
2015
Q1
$1K Hold
87
﹤0.01% 949
2014
Q4
$1K Hold
87
﹤0.01% 764
2014
Q3
$1K Hold
87
﹤0.01% 863
2014
Q2
$1K Hold
87
﹤0.01% 875
2014
Q1
$1K Hold
87
﹤0.01% 860
2013
Q4
$1K Buy
+87
New +$456 ﹤0.01% 846

Other funds holding CORV

Compagnie Lombard Odier SCmA's CORV Position: Q1 2017 in Review

Compagnie Lombard Odier SCmA sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q1 2017, closing a stake of 87 shares.

Compagnie Lombard Odier SCmA first reported a position in CORV in Q4 2013 and held it in 13 quarters. The position peaked at $1K in Q4 2015. 32 funds tracked by Wall St. Rank hold CORV as of Q1 2017.

  • Compagnie Lombard Odier SCmA reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q1 2017 after selling out during the quarter.
  • Compagnie Lombard Odier SCmA sold 87 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q1 2017.
  • Compagnie Lombard Odier SCmA first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q4 2013 and held it in 13 quarters.
  • Compagnie Lombard Odier SCmA's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $1K in Q4 2015.
  • 32 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q1 2017.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q1 2017, filed 15 May 2017.